Fig. 4
From: Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with NTRK family mutations
The association between NTRK mutation and PD-L1 expression, tumor mutational burden (TMB), blood TMB (bTMB). A-D: The association between NTRK, NTRK1, NTRK2, NTRK3 mutation and PD-L1 expression. E-H: The association between NTRK, NTRK1, NTRK2, NTRK3 mutation and bTMB levels (all P < 0.05). I-L: The association between NTRK, NTRK1, NTRK2, NTRK3 mutation and TMB levels (all P < 0.001)